Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Vibrant raises $7.5m for vibrating capsule for constipation treatment Vibrant, an Israeli developer of treatments of constipation relief and other gastrointestinal problems, has raised $7.5 million in… bySrinathMarch 27, 2021
